bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.10.17.683117

Human cell line tropism, interferon system interactions and NSs mechanisms by the Ntepes and Gabek Forest phleboviruses

Abstract

Phleboviruses are a large genus within the family Phenuiviridae, class Bunyaviricetes. These arboviruses are present all over the world, and several members can cause severe disease. New viruses are continuously discovered, but rarely isolated and analysed in cell culture to assess their risk to humans. Here, we describe the in cellulo characteristics for two closely related African phleboviruses, Ntepes virus (NTPV) and Gabek Forest virus (GFV), for which human seroprevalence has been reported but pathogenicity remains unknown. For both viruses, human cell lines from liver, lung, and kidney were permissive, and their capacity to suppress and cope with the antiviral type I interferon (IFN) system was comparable to Rift Valley fever phlebovirus MP-12. Consequently, their non-structural protein NSs, a well- known virulence factor of Phenuiviridae, was able to interfere with both the induction and signaling of IFN. Blockade of IFN induction is a conserved NSs activity, and we found that in the case of NTPV and GFV, the NSs targets MAVS (Mitochondrial antiviral signaling protein), a cellular signaling adapter which plays a key role in the induction of IFN gene expression. NTPV and GFV NSs thereby strongly and specifically bind the N-terminal CARD (Caspase recruitment domain) of human MAVS, thus occupying the very domain that is required for MAVS to relay the signal coming from the virus sensor RIG-I. Thus, the cell line tropism, IFN system interactions and NSs mechanisms suggest that NTPV and GFV fulfill the in cellulo criteria for successful infection of humans. ImportanceChikungunyna virus and Zika virus are just two recent examples of arboviruses that have emerged and caused outbreaks in humans. We investigated whether Ntepes virus (NTPV) and Gabek Forest virus (GFV), two closely related bunyaviruses of the genus Phlebovirus with human seroprevalence in certain African regions, have cell culture characteristics that are compatible with a risk for humans. Both viruses were able to infect human cell lines derived from inner organs, and could circumvent the human antiviral interferon system similar to strain MP-12 of the established Rift Valley fever phlebovirus. Specifically, we identified that the interferon antagonists NSs of NTPV and GFV could strongly and specifically bind to a domain in the cellular adaptor protein MAVS that is crucial for the upregulation of the antiviral interferon system. NTPV and GFV may thus have potential to further adapt to humans.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pickin, M., Felgenhauer, U., Tchouassi, D. P., Junglen, S., Weber, F.. 2025-10-17. Human cell line tropism, interferon system interactions and NSs mechanisms by the Ntepes and Gabek Forest phleboviruses. https://doi.org/10.1101/2025.10.17.683117

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗